Agilent Technologies, Inc.

New York Stock Exchange
Back to all articles
Somewhat Bullish +35

Assessing Agilent Technologies (A) Valuation After Recent Share Price Softness and Long Term Gains

📉 Agilent Technologies shares have softened recently with negative returns over the past month and three months despite positive performance over five years.

💵 The current share price is US$121.38, reflecting a 9.32% return in the last 30 days and a 19.13% return over the past 90 days.

📈 The company has generated annual revenue of US$7.07 billion and net income of US$1.29 billion over the long term.

💎 Simply Wall St calculates a fair value of US$169.67 per share, indicating the stock is potentially undervalued by roughly 37%.

🔄 The company is investing in higher margin recurring revenue streams such as consumables, software, services, and digital platforms.

📉 CrossLab and service segments are delivering consistent mid-single digit growth along with high customer satisfaction levels.

⚠️ Future upside could be challenged if tariff-related costs remain elevated or if demand weakens in academic and government markets.

🛡 The analysis includes a value score of 4 and notes a modest intrinsic discount at the current price level.

📉 Investors are urged to review the underlying growth, profitability, and valuation assumptions behind the fair value forecast.

💰 Simply Wall St offers alternative investment options including dividend fortress stocks and high-quality undiscovered gems.

🏦 The article is not financial advice but is based on historical data and analyst forecasts using an unbiased methodology.

📊 Readers can explore sector screeners for 28 healthcare AI stocks or review resilient stocks with low risk scores.

Bullish Signals
  • Agilent Technologies maintains positive long-term performance with a 5-year total shareholder return of 8.14% despite recent short-term share price softness.
  • The company trades at US$121.38, significantly below its calculated fair value of US$169.67 per share, suggesting it is currently undervalued by approximately US$48.29 per share.
  • Annual revenue of US$7.07 billion and net income of US$1.29 billion demonstrate strong fundamental financial health supporting the valuation narrative.
  • Strategic investments in higher margin recurring revenue streams, including consumables, software, services, and digital platforms, are gaining traction to drive future growth.
  • CrossLab and services segments are delivering consistent mid single digit growth with high customer satisfaction, indicating further margin expansion potential.
  • The stock has delivered positive returns over 30 days (9.32%) and 90 days (19.13%), showing underlying buyer interest despite recent momentum softening.
Risk Factors
  • Agilent Technologies experienced negative returns over the past month and past three months despite long-term gains, indicating recent share price softness.
  • The stock is trading at $121.38, which is significantly below its fair value estimate of $169.67 per share, suggesting a potential misalignment or that market prices may have already accounted for future growth concerns.
  • Upward momentum could be challenged if tariff-related costs remain elevated, potentially eroding margins and profitability.
  • Demand from academic and government markets, which are key funding sources, faces pressure that could weigh on revenue and overall business stability.
  • The analysis relies on historical data and analyst forecasts without incorporating the latest price-sensitive company announcements or qualitative material, introducing potential timing risks.
Full Analysis
Agilent Technologies (A) has recently attracted investor attention amidst mixed share performance, showing positive long-term growth while experiencing recent softness. The stock currently trades at US$121.38, which contrasts with a calculated fair value of US$169.67, suggesting the market may be undervaluing the company. Despite negative returns over the past month and three months as highlighted in general performance metrics, specific data indicates a 30-day share price return of 9.32% and a 90-day return of 19.13%, while the 5-year total shareholder return stands at a resilient 8.14%. The company's fundamentals remain robust with annual revenue of US$7.07 billion and net income of US$1.29 billion, underpinned by a value score of 4 and a modest intrinsic discount. The analysis highlights Agilent's strategic shift toward higher margin recurring revenue streams, including consumables, software, services, and digital platforms. Notably, the CrossLab platform and related services are delivering consistent mid-single-digit growth coupled with high customer satisfaction, which is expected to drive further margin expansion and enhance earnings stability in future periods. This valuation narrative points to significant potential upside, as the fair value of US$169.67 represents a clear gap above the last close price of US$121.38, assuming the market continues to recognize long-term growth drivers rather than being influenced by short-term share price volatility. However, this positive outlook faces potential headwinds that investors must consider when assessing the investment thesis. Key risks include elevated tariff-related costs that could impact profitability and funding pressures within academic and government markets which might weigh on overall demand for the company's products and services. The financial analysis suggests that while the stock may appear undervalued based on intrinsic value models, the validity of higher fair value assumptions depends heavily on successful execution of growth strategies and the absence of significant external economic disruptions. Investors are encouraged to review these underlying numbers and specific risks to form a balanced view, considering whether current market pricing already accounts for future growth potential or if a genuine opening exists for long-term investors.